Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

被引:33
作者
Schuller, Elisabeth [1 ]
Made, Christoph S. [1 ]
Woelfl, Gabriele [1 ]
Kaltenboeck, Astrid [1 ]
Dewasthaly, Shailesh [1 ]
Tauber, Erich [1 ]
机构
[1] Intercell AG, A-1030 Vienna, Austria
关键词
IC51; Japanese encephalitis; Vaccination regimen; RAPID IMMUNIZATION SCHEDULE; TBE VACCINATION; VIRUS-VACCINE; SAFETY; IMMUNOGENICITY; TRIAL; HOLIDAY; BALI; LIVE;
D O I
10.1016/j.vaccine.2008.12.062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The standard administration of the investigational Japanese encephalitis vaccine IC51 is 2 doses of 6 mu g with a 28-day interval. This study investigated the immunogenicity of a single-immunization, high-dose regimen (1 x 12 mu g) compared to the 2-injection, standard regimen to determine the immune response that one, high-close injection can confer. The single, high-dose regimen resulted in about 60% seroconversion rate (SCR) at 10 days after administration, but it did not reach the almost 100% SCR achieved by the 2-dose standard administration at Day 35. The standard regimen conferred essentially 100% seroconversion already 7 days after the second immunization. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2188 / 2193
页数:6
相关论文
共 19 条
[1]   Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days [J].
Buhl, MR ;
Black, FT ;
Andersen, PL ;
Laursen, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (02) :189-189
[2]  
Burke D. S., 1988, The arboviruses: epidemiology and ecology. Volume III., P63
[3]  
Igarashi Akira, 1992, World Health Statistics Quarterly, V45, P299
[4]   Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand [J].
Lehtinen, Ville A. ;
Huhtamo, Eili ;
Siikamaki, Heli ;
Vapalahti, Olli .
JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (01) :93-95
[5]   Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): Results of a randomized trial with 26,239 subjects [J].
Liu, ZL ;
Hennessy, S ;
Strom, BL ;
Tsai, TF ;
Wan, CM ;
Tang, SC ;
Xiang, CF ;
Bilker, WB ;
Pan, XP ;
Yao, YJ ;
Xu, ZW ;
Halstead, SB .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1366-1369
[6]   A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis [J].
Lyons, Arthur ;
Kanesa-thasan, Niranjan ;
Kuschner, Robert A. ;
Eckels, Kenneth H. ;
Putnak, Robert ;
Sun, Wellington ;
Burge, Robert ;
Towle, Andrew C. ;
Wilson, Paul ;
Tauber, Erich ;
Vaughn, David W. .
VACCINE, 2007, 25 (17) :3445-3453
[7]   Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen [J].
Monath, TP ;
Guirakhoo, F ;
Nichols, R ;
Yoksan, S ;
Schrader, R ;
Murphy, C ;
Blum, P ;
Woodward, S ;
McCarthy, K ;
Mathis, D ;
Johnson, C ;
Bedford, P .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (08) :1213-1230
[8]   Tick-borne encephalitis (TBE) vaccination:: Applying the most suitable vaccination schedule [J].
Schoendorf, I. ;
Beran, J. ;
Cizkova, D. ;
Lesna, V. ;
Banzhoff, A. ;
Zent, O. .
VACCINE, 2007, 25 (08) :1470-1475
[9]   Tick-borne encephalitis (TBE) vaccination in children -: Advantage of the rapid immunization schedule (i.e., days 0, 7, 21) [J].
Schoendorf, Ines ;
Ternak, Gabor ;
Oroszlan, Gyorgy ;
Nicolay, Uwe ;
Banzhoff, Angelika ;
Zent, Olaf .
HUMAN VACCINES, 2007, 3 (02) :42-47
[10]   Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study [J].
Schuller, E. ;
Jilma, B. ;
Voicu, V. ;
Golor, G. ;
Kollaritsch, H. ;
Kaltenboeck, A. ;
Klade, C. ;
Tauber, E. .
VACCINE, 2008, 26 (34) :4382-4386